Australia markets open in 4 hours 1 minute

BioSyent Inc. (RX.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
10.50+0.49 (+4.90%)
At close: 03:58PM EDT
Full screen
Previous close10.01
Open9.93
Bid9.50 x 0
Ask10.50 x 0
Day's range9.93 - 10.75
52-week range7.03 - 10.75
Volume5,644
Avg. volume8,403
Market cap121.635M
Beta (5Y monthly)0.95
PE ratio (TTM)18.10
EPS (TTM)0.58
Earnings date20 Aug 2024 - 26 Aug 2024
Forward dividend & yield0.18 (1.71%)
Ex-dividend date31 May 2024
1y target est9.65
  • GlobeNewswire

    BioSyent In-Licenses Endocrinology Product for Canada

    MISSISSAUGA, Ontario, June 12, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. (“BioSyent Pharma”), has entered into an agreement with a European partner for an exclusive license to register, market, sell and distribute a new endocrinology product in Canada. BioSyent Pharma and its European partner have agreed to seek Health Canada approval of the product by the end of 2024. “We are

  • Simply Wall St.

    BioSyent (CVE:RX) Could Be A Buy For Its Upcoming Dividend

    Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

  • Simply Wall St.

    BioSyent (CVE:RX) Has Affirmed Its Dividend Of CA$0.045

    The board of BioSyent Inc. ( CVE:RX ) has announced that it will pay a dividend of CA$0.045 per share on the 15th of...